Ark’s Flagship Fund Sold 56,975 Shares of Tesla
According to data from Cathie Wood, ARK Invest, its funds continue to reduce Tesla’s holdings and buy Robin Hood stocks on dips. In addition, Exact Sciences, a biotechnology stock, is also aggressively entering the market.
According to data, ARK Innovation ETF , Ark’s flagship fund, sold 56,975 shares of Tesla, valued at approximately US$63.5 million. The stock gods expressed their intention to reduce Tesla’s holdings in September.
According to FactSet data, ARKK’s return on investment last year was as high as 152%, but it has fallen 13.43% so far this year. Tesla accounts for 10.28% of the fund and is its largest component stock. Tesla rose 0.63% to $1,116 per share on Wednesday.
In addition, data on Wednesday also showed that another ARK Fintech Innovation ETF under Robin Hood bought 233,353 shares on dips when Robin Hood fell for 7 days. Robin Hood rose 1.19% on Wednesday to $27.98 per share.
In addition, the stock god seems to have bought a total of 237,754 shares from Exact Sciences , its ARKK and ARK Genomic Revolution ETF.
Exact Sciences is a biotechnology company that provides non-invasive colorectal cancer detection. The company’s product, Cologuard, uses stool samples for DNA screening to identify early colorectal cancer symptoms. The stock rose 3.57% on Wednesday to $88.09 per share.
Before the deadline, Ark Investment did not comment on the changes in its fund holdings.
Ark's Flagship Fund Sold 56,975 Shares of Tesla - /10
According to data from Cathie Wood, ARK Invest, its funds continue to reduce Tesla's holdings and buy Robin Hood stocks on dips. In addition, Exact Sciences, a biotechnology stock, is also aggressively entering the market.